Literature DB >> 19329989

The GARS gene is rarely mutated in Japanese patients with Charcot-Marie-Tooth neuropathy.

Akiko Abe1, Kiyoshi Hayasaka.   

Abstract

Charcot-Marie-Tooth neuropathy (CMT) is an extremely common but heterogeneous inherited neuropathy. It has been classified into two forms: demyelinating and axonal. The dominant axonal form, CMT2, has been further subdivided through linkage study and 15 loci and 10 genes have been reported. For the glycyl-tRNA synthetase (GARS) gene, a CMT2-causing gene, 10 mutations have been reported to date. We studied the GARS in 89 Japanese patients with axonal CMT and detected a novel heterozygous Pro244Leu (c.893C>T) mutation in a patient showing adolescent onset and early upper limb involvement. Results of our study indicate that GARS mutation is a rare cause of CMT2 among Japanese patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19329989     DOI: 10.1038/jhg.2009.25

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  13 in total

Review 1.  Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease.

Authors:  Rebecca Meyer-Schuman; Anthony Antonellis
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

2.  Charcot-Marie-Tooth disease type 2D with a novel glycyl-tRNA synthetase gene (GARS) mutation.

Authors:  Ayumi Hamaguchi; Chiho Ishida; Kazuo Iwasa; Akiko Abe; Masahito Yamada
Journal:  J Neurol       Date:  2010-02-19       Impact factor: 4.849

3.  Allele-specific RNA interference prevents neuropathy in Charcot-Marie-Tooth disease type 2D mouse models.

Authors:  Kathryn H Morelli; Laurie B Griffin; Nettie K Pyne; Lindsay M Wallace; Allison M Fowler; Stephanie N Oprescu; Ryuichi Takase; Na Wei; Rebecca Meyer-Schuman; Dattatreya Mellacheruvu; Jacob O Kitzman; Samuel G Kocen; Timothy J Hines; Emily L Spaulding; James R Lupski; Alexey Nesvizhskii; Pedro Mancias; Ian J Butler; Xiang-Lei Yang; Ya-Ming Hou; Anthony Antonellis; Scott Q Harper; Robert W Burgess
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

4.  Dispersed disease-causing neomorphic mutations on a single protein promote the same localized conformational opening.

Authors:  Weiwei He; Hui-Min Zhang; Yeeting E Chong; Min Guo; Alan G Marshall; Xiang-Lei Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-07       Impact factor: 11.205

Review 5.  Predicting the pathogenicity of aminoacyl-tRNA synthetase mutations.

Authors:  Stephanie N Oprescu; Laurie B Griffin; Asim A Beg; Anthony Antonellis
Journal:  Methods       Date:  2016-11-20       Impact factor: 3.608

Review 6.  GARS axonopathy: not every neuron's cup of tRNA.

Authors:  William W Motley; Kevin Talbot; Kenneth H Fischbeck
Journal:  Trends Neurosci       Date:  2010-02       Impact factor: 13.837

7.  Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations.

Authors:  Laurie B Griffin; Reiko Sakaguchi; David McGuigan; Michael A Gonzalez; Charles Searby; Stephan Züchner; Ya-Ming Hou; Anthony Antonellis
Journal:  Hum Mutat       Date:  2014-11       Impact factor: 4.878

Review 8.  To charge or not to charge: mechanistic insights into neuropathy-associated tRNA synthetase mutations.

Authors:  Rachel C Wallen; Anthony Antonellis
Journal:  Curr Opin Genet Dev       Date:  2013-03-04       Impact factor: 5.578

Review 9.  Peripheral neuropathy via mutant tRNA synthetases: Inhibition of protein translation provides a possible explanation.

Authors:  Erik Storkebaum
Journal:  Bioessays       Date:  2016-06-28       Impact factor: 4.345

10.  Compound heterozygous mutations in glycyl-tRNA synthetase (GARS) cause mitochondrial respiratory chain dysfunction.

Authors:  Michael Nafisinia; Lisa G Riley; Wendy A Gold; Kaustuv Bhattacharya; Carolyn R Broderick; David R Thorburn; Cas Simons; John Christodoulou
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.